Editas Medicine Inc (EDIT)
7.85
-0.15
(-1.88%)
USD |
NASDAQ |
Sep 22, 16:00
7.90
+0.05
(+0.64%)
After-Hours: 20:00
Editas Medicine Price: 7.85 for Sept. 22, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2023 | 8.00 | 8.115 | 7.74 | 7.85 | 1.263M |
| Sep 21, 2023 | 7.85 | 8.045 | 7.71 | 8.00 | 1.119M |
| Sep 20, 2023 | 8.00 | 8.105 | 7.91 | 7.95 | 974684.0 |
| Sep 19, 2023 | 8.01 | 8.099 | 7.95 | 7.99 | 1.291M |
| Sep 18, 2023 | 8.39 | 8.51 | 7.99 | 8.01 | 1.725M |
| Sep 15, 2023 | 8.41 | 8.489 | 8.29 | 8.39 | 3.589M |
| Sep 14, 2023 | 8.50 | 8.53 | 8.32 | 8.40 | 1.008M |
| Sep 13, 2023 | 9.06 | 9.10 | 8.45 | 8.47 | 1.501M |
| Sep 12, 2023 | 9.17 | 9.44 | 8.98 | 9.00 | 922891.0 |
| Sep 11, 2023 | 9.05 | 9.215 | 8.84 | 9.17 | 1.036M |
| Sep 08, 2023 | 8.91 | 9.14 | 8.89 | 9.02 | 818745.0 |
| Sep 07, 2023 | 9.00 | 9.035 | 8.875 | 8.91 | 905069.0 |
| Sep 06, 2023 | 8.82 | 9.14 | 8.77 | 9.12 | 1.077M |
| Sep 05, 2023 | 9.03 | 9.24 | 8.78 | 8.83 | 1.444M |
| Sep 01, 2023 | 8.98 | 9.25 | 8.96 | 9.08 | 1.033M |
| Aug 31, 2023 | 9.05 | 9.135 | 8.88 | 8.91 | 913725.0 |
| Aug 30, 2023 | 9.11 | 9.22 | 8.940 | 9.04 | 954092.0 |
| Aug 29, 2023 | 8.99 | 9.125 | 8.89 | 9.06 | 688271.0 |
| Aug 28, 2023 | 8.79 | 9.02 | 8.79 | 9.02 | 860970.0 |
| Aug 25, 2023 | 8.82 | 8.93 | 8.55 | 8.77 | 1.051M |
| Aug 24, 2023 | 8.76 | 8.925 | 8.64 | 8.81 | 1.177M |
| Aug 23, 2023 | 8.81 | 9.01 | 8.73 | 8.75 | 931865.0 |
| Aug 22, 2023 | 8.65 | 8.81 | 8.445 | 8.79 | 876080.0 |
| Aug 21, 2023 | 8.64 | 8.70 | 8.345 | 8.62 | 1.102M |
| Aug 18, 2023 | 8.35 | 8.751 | 8.33 | 8.66 | 1.147M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.36
Minimum
Apr 12 2023
90.58
Maximum
Jan 08 2021
25.95
Average
24.47
Median
Price Benchmarks
| Vertex Pharmaceuticals Inc | 349.53 |
| Ligand Pharmaceuticals Inc | 59.08 |
| Syros Pharmaceuticals Inc | 3.98 |
| Apellis Pharmaceuticals Inc | 43.77 |
| Tango Therapeutics Inc | 10.32 |
Price Related Metrics
| PS Ratio | 28.23 |
| PEG Ratio | -0.2754 |
| Price to Book Value | 1.602 |
| Earnings Yield | -37.71% |
| Market Cap | 640.82M |
| PEGY Ratio | -0.2754 |